CBGA: What It Is, Effects and Safety | PatientsCann UK

CBGA

CBGA, "the mother acid"

pronounced: kan-uh-bih-jer-OL-ik AS-id

The true "mother" - the acid the plant turns into every other cannabinoid.

Acidic (raw) cannabinoidFormula: C22H32O4Intoxicating: No
Type
Acidic (raw)
Formula
C22H32O4
Intoxicating
No
Key focus
Precursor

Cannabigerolic acid · 360.5 g/mol

The molecule

Chemical structure

This is the accurate skeletal structure of CBGA, drawn from PubChem data. Each corner and line-end is a carbon atom, and the red O marks oxygen. Its formula is C22H32O4 and it weighs 360.5 g/mol.

PrecursorMetabolicAnti-inflammatoryRaw / unheated

About

What is CBGA?

Cannabigerolic acid, or CBGA, is where the whole cannabinoid story begins. It is the very first cannabinoid the cannabis plant makes, and it is often called the "mother cannabinoid" because everything else is built from it.

On its own, CBGA is not intoxicating. It is a raw acid, and most of it is quickly turned into other cannabinoid acids as the plant grows.

In the body

How CBGA Works

CBGA does not act strongly on the CB1 or CB2 receptors directly. Its main role is as a building block. Inside the plant, three different enzymes take CBGA and turn it into THCA, CBDA or CBCA, which then become THC, CBD and CBC when heated.

Because it is a starting material rather than a finished product, CBGA has been studied less as a medicine, though early research is beginning to look at it for metabolism and inflammation.

Receptor snapshot

Where CBGA Acts

The endocannabinoid system has two main receptors. Here is how strongly CBGA acts on each.

CB1Brain & nervous system
None

Does not act on CB1 directly.

CB2Immune system & body
None

Does not act on CB2 directly.

Beyond CB1 and CB2: The starting molecule. The plant’s enzymes turn CBGA into THCA, CBDA and CBCA. Early research looks at PPAR receptors and metabolism.

In the plant

How CBGA is Made

CBGA is built when the plant joins a molecule called olivetolic acid with a terpene building block, geranyl pyrophosphate, using an enzyme called CBGA synthase.

From there, CBGA is the crossroads of the whole family. If it is simply heated, it becomes CBG. If the plant's enzymes act on it first, it becomes the acids that lead to THC, CBD and CBC.

PathwayCBGAadd heat →CBG

Good to know

Safety and Side Effects

There is very little human safety data on CBGA, because it is usually converted into other cannabinoids rather than used on its own. It is not intoxicating.

Treat any CBGA product as experimental and speak to your prescriber before trying it.

Questions

CBGA: Common Questions

What is CBGA?
CBGA (cannabigerolic acid) is the first cannabinoid the cannabis plant makes. It is often called the "mother cannabinoid" because the plant’s enzymes turn it into the acids that become THC, CBD and CBC.
Does CBGA turn into CBG?
Yes. When CBGA is heated it loses its acid group (a process called decarboxylation) and becomes CBG.
Back to full Cannabinoids Guide
Important: This page is for education only. It is not medical advice. Cannabinoid research is still developing, and many studies have been done in cells or animals rather than people. Always speak to your prescriber before changing your treatment. PatientsCann UK does not recommend any specific cannabis product.

References

  1. Nachnani, R., Raup-Konsavage, W.M. and Vrana, K.E. (2021) 'The pharmacological case for cannabigerol', Journal of Pharmacology and Experimental Therapeutics, 376(2), pp. 204-212. doi: 10.1124/jpet.120.000340.
  2. Morales, P., Hurst, D.P. and Reggio, P.H. (2017) 'Molecular targets of the phytocannabinoids: a complex picture', Progress in the Chemistry of Organic Natural Products, 103, pp. 103-131. doi: 10.1007/978-3-319-45541-9_4.
  3. National Center for Biotechnology Information (2025) PubChem Compound Database. Bethesda: U.S. National Library of Medicine. Available at: https://pubchem.ncbi.nlm.nih.gov (Accessed: 29 July 2026).
  4. Izzo, A.A., Borrelli, F., Capasso, R., Di Marzo, V. and Mechoulam, R. (2009) 'Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb', Trends in Pharmacological Sciences, 30(10), pp. 515-527. doi: 10.1016/j.tips.2009.07.006.